PR Web09.30.16
AxioMed has received approval from the Therapeutic Goods Administration (TGA) of Australia to market and sell its cervical and lumbar Freedom Viscoelastic Disc Replacement.
The approval, effective immediately, marks an important milestone for AxioMed as the company increases its presence both internationally and domestically in the United States in preparation for U.S. Food and Drug Administration approval. The AxioMed viscoelastic disc is a next-generation disc replacement that restores natural disc height, stability, and motion in the human spine.
In response to the TGA approval of the AxioMed discs, company President Jake Lubinski will go to Australia from Oct. 7-12 to meet with surgeons in Brisbane, Sydney, and Melbourne to discuss the benefits of a viscoelastic disc replacement. “The evolution of total joint technology now enables restoration of joint motion with a high degree of patient satisfaction. AxioMed believes it can replicate this success in spine with their innovative and advanced viscoelastic total disc replacements,” said Lubinski. “We’re excited to make our entrance into one of the most advanced markets globally in total disc replacement”
Founded in 2001, AxioMed began its journey of proving the Freedom Disc through clinical studies in the United States and Europe, research, development and testing. In 2014, KICVentures recognized the disc’s potential and acquired the company into its healthcare portfolio. AxioMed owns an exclusive viscoelastic material license on its proprietary Freedom Disc technology.
The approval, effective immediately, marks an important milestone for AxioMed as the company increases its presence both internationally and domestically in the United States in preparation for U.S. Food and Drug Administration approval. The AxioMed viscoelastic disc is a next-generation disc replacement that restores natural disc height, stability, and motion in the human spine.
In response to the TGA approval of the AxioMed discs, company President Jake Lubinski will go to Australia from Oct. 7-12 to meet with surgeons in Brisbane, Sydney, and Melbourne to discuss the benefits of a viscoelastic disc replacement. “The evolution of total joint technology now enables restoration of joint motion with a high degree of patient satisfaction. AxioMed believes it can replicate this success in spine with their innovative and advanced viscoelastic total disc replacements,” said Lubinski. “We’re excited to make our entrance into one of the most advanced markets globally in total disc replacement”
Founded in 2001, AxioMed began its journey of proving the Freedom Disc through clinical studies in the United States and Europe, research, development and testing. In 2014, KICVentures recognized the disc’s potential and acquired the company into its healthcare portfolio. AxioMed owns an exclusive viscoelastic material license on its proprietary Freedom Disc technology.